Hi all !
Hoping for some input/thoughts. thank you !
22 yo AAF
IIH dx since 2014 ; OP 55 and normal CSF
11-2025 : seen at our hospital & by one of our ophtho
Had LP with OP = 50 (on lasix 80-100mg qd)
Neurology restarted on diamox
OCT G146 OD (was 142 LV), G 152 OS (was 175 LV)
Gmax 192 OD & 195 OS in 7/2021
HVF enlarged blind spots OU
12-2025 I started to see her ; she was on 1000mg diamox and exam no disc edema with normal HVF and good RNFL OU
Was also started on Zepbound for weight loss
Saw her 3-2026 with very stable exam - kept diamox dosing same
6-2026 fu visit: she reports a few days after our apt she noted change in her left eye
pt woke up with decreased vision OS (describes a large gray line in the center of the vision) and persistent sharp left eye pain (but ?denies pain with eye movements). This occurred twice (first episode was transient and symptoms self-resolved, whereas symptoms were persistent after second episode which occurred two weeks after first episode). The vision decline has been stable since
She did not call or come in sooner for re-eval
6-2026 eval shows APD OS ; VA 20/1250 ; no color plates and atrophy on OCT ; G OS now 74
OD stable and no disc edema
Initiated workup w repeat MRI and labs
MRI with still signs of increased ICP as before and now OS with mild enhancement of the optic nerve but no thickening or T2 signal abnormality
Labs: B12, folate, bartonella, NMO, MOG, RF, Lyme, Lysozyme, Syphilis, CRP, Anti dsDNA, ANA, ANCA, ACE all WNL
7-2026 : 1 month follow up vision at 20/500 so with some improvement ; rest of exam stable
Clearly there is new optic neuropathy/neuritis component OS though I am unclear of etiology
Pt is declining new LP w OP and CSF analysis and declined IV steroids.
Any thoughts on what else I can do here and on differential for this new finding in the setting of history of IIH which has been well controlled.
I also thought about NAION in setting of Zepbound use but unsure if that would be accompanied by intraorbital optic nerve enhancement on the MRI